Stay updated on Pembrolizumab for Metastatic Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Metastatic Prostate Cancer Clinical Trial page.

Latest updates to the Pembrolizumab for Metastatic Prostate Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedRevision tag on the page updated from v3.6.5 to v3.6.6. This is a minor maintenance update that does not alter the study content or its key details.SummaryDifference0.1%

- Check26 days agoNo Change Detected
- Check41 days agoChange DetectedRepresents a software version update for the page, from v3.6.4 to v3.6.5. This deployment likely includes fixes or minor improvements and does not change the study content shown on the page.SummaryDifference0.1%

- Check55 days agoChange DetectedThe page shows Revision: v3.6.4 replacing Revision: v3.6.3. This appears to be a minor backend update to the study page with no changes to visible content or data.SummaryDifference0.1%

- Check76 days agoChange DetectedThe revision label was updated from v3.6.2 to v3.6.3, signaling a newer version of the study protocol/document referenced on the page.SummaryDifference0.1%

- Check84 days agoChange DetectedThe document revision was updated from v3.6.0 to v3.6.2, signaling a newer version of the trial-related documentation linked on the page. This reflects an update to the document's version rather than changes to the page's core content.SummaryDifference0.1%

- Check98 days agoChange DetectedThe study page now indicates that recruitment has ended, and new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) were added to guide users in understanding and interacting with the study record.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab for Metastatic Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Metastatic Prostate Cancer Clinical Trial page.